Status:
COMPLETED
Osteoradionecrosis and PENTOCLO Protocol: Retrospective Study
Lead Sponsor:
University Hospital, Brest
Conditions:
Osteoradionecrosis of Jaw
Eligibility:
All Genders
18+ years
Brief Summary
osteoradionecrosis (ORN) affects up to 30% of irradiated patients and can occur up to several decades after stopping treatment. Differents therapeutics exist but there is no consensus concerning the m...
Eligibility Criteria
Inclusion
- Patient over 18 being or having been treated by pentoclo combination for an osteoradionecrosis of the jaw
Exclusion
- Tumoral recidivism
- Precocious stop of pentoclo
Key Trial Info
Start Date :
June 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04097847
Start Date
June 2 2017
End Date
April 1 2019
Last Update
November 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609